Cargando…
Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer
BACKGROUND: The majority (90%) of anal cancers are human papillomavirus (HPV)-driven, identified using immunochemistry for p16. Compared with HPV− patients, those with HPV+ disease generally show improved survival, although relapse rates around 25% indicate a need for further stratification of this...
Autores principales: | Gilbert, Duncan C, Serup-Hansen, Eva, Linnemann, Dorte, Høgdall, Estrid, Bailey, Charles, Summers, Jeff, Havsteen, Hanne, Thomas, Gareth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815814/ https://www.ncbi.nlm.nih.gov/pubmed/26730577 http://dx.doi.org/10.1038/bjc.2015.448 |
Ejemplares similares
-
Biomarkers in anal cancer: from biological understanding to stratified treatment
por: Jones, Christopher M, et al.
Publicado: (2017) -
Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy
por: Baumann, Brian C., et al.
Publicado: (2020) -
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)
por: Lee, Jen Y., et al.
Publicado: (2020) -
Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer
por: Calmels, Lucie, et al.
Publicado: (2022) -
MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability
por: Boisen, Mogens Karsbøl, et al.
Publicado: (2015)